Daicel Corporation

BST:9DC Stock Report

Market Cap: €2.3b

Daicel Past Earnings Performance

Past criteria checks 4/6

Daicel has been growing earnings at an average annual rate of 35.3%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 8.5% per year. Daicel's return on equity is 15.1%, and it has net margins of 10.1%.

Key information

35.3%

Earnings growth rate

37.5%

EPS growth rate

Chemicals Industry Growth12.4%
Revenue growth rate8.5%
Return on equity15.1%
Net Margin10.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Daicel makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BST:9DC Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24576,74058,13678,66922,286
30 Jun 24572,82657,03976,07322,286
31 Mar 24558,05655,83474,60122,286
31 Dec 23547,78955,34374,95920,646
30 Sep 23542,79848,22375,92320,646
30 Jun 23540,84746,76377,02420,646
31 Mar 23538,02640,68277,65720,646
31 Dec 22529,47137,30079,03519,667
30 Sep 22509,35231,41875,63019,667
30 Jun 22484,56027,87471,95619,667
31 Mar 22467,93731,25468,24319,667
31 Dec 21455,18831,98166,90018,567
30 Sep 21443,03938,48665,53418,567
30 Jun 21422,01331,36163,74818,567
31 Mar 21393,56819,71361,14118,567
31 Dec 20381,39411,56557,94620,328
30 Sep 20377,491-3,43258,57420,328
30 Jun 20391,85529159,84320,328
31 Mar 20412,8264,97861,07820,328
31 Dec 19420,7146,87363,31419,690
30 Sep 19440,29824,59063,55119,690
30 Jun 19453,22130,21463,40219,690
31 Mar 19464,85935,30162,91219,690
31 Dec 18474,18941,65663,24218,015
30 Sep 18469,16339,87561,96418,015
30 Jun 18466,19738,36160,87118,015
31 Mar 18462,95637,06260,25418,015
31 Dec 17463,05039,38861,37816,117
30 Sep 17459,29443,72059,97616,117
30 Jun 17448,64641,74658,32616,117
31 Mar 17440,06143,19856,40916,117
31 Dec 16430,45038,73355,72314,638
30 Sep 16433,19238,02655,12814,638
30 Jun 16440,13139,23355,13114,638
31 Mar 16449,87840,31354,84114,638
31 Dec 15452,85139,11069,2590
30 Sep 15451,57535,64068,2820
30 Jun 15448,71433,73966,4960
31 Mar 15443,77631,25364,8440
31 Dec 14443,62329,85049,94312,822
30 Sep 14435,51427,65948,83912,822
30 Jun 14427,41225,58947,33512,822
31 Mar 14413,78622,84459,6670
31 Dec 13396,04522,60858,7740

Quality Earnings: 9DC has high quality earnings.

Growing Profit Margin: 9DC's current net profit margins (10.1%) are higher than last year (8.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 9DC's earnings have grown significantly by 35.3% per year over the past 5 years.

Accelerating Growth: 9DC's earnings growth over the past year (20.6%) is below its 5-year average (35.3% per year).

Earnings vs Industry: 9DC earnings growth over the past year (20.6%) exceeded the Chemicals industry 7.2%.

Return on Equity

High ROE: 9DC's Return on Equity (15.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y